Multidimensional Characterization for Protein
Antibody drugs have large molecular weight, complex structure and post-translational modification (PTM). Antibody drugs come from living cells and contain a variety of impurities related to products and processes. Different methods are used to analyze the samples from multiple angles to control the structure, purity, activity and impurities of the samples due to the complexity of protein drugs.
The antibodies were analyzed with dimensions of concentration, content, purity analysis, post-translational modification of primary structure and advanced structure, residue detection, activity detection and so on.
Comprehensive and diverse characterization analysis, comprehensive quality management system, international advanced instruments and equipment, and rich team experience to ensure the accuracy, stability, compliance and traceability of analysis results.
1. Comprehensive and diverse characterization analysis
Analytical Characterization covers concentration, content, purity analysis, post-translational modification of primary and advanced structure, residue detection, activity detection and other dimensions.
2. Comprehensive and strict quality management
The platform has established a comprehensive and strict quality management system to ensure compliance, authenticity, reliability and traceability of the results of the analysis.
3. International advanced instruments and equipment
The platform has international advanced instruments and equipment and standardized operating methods to ensure that the characterization and analysis results are accurate and stable.
4. Team members with rich experience
Our team has completed hundreds of related analysis projects and has rich experience in the characterization and analysis of different types of molecules such as monoclonal antibodies, multi antibodies and fusion proteins.
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.Learn more
After the base is put into operation, SMOC’s capability to provide genetically modified rat/mouse models and technical services including gene function research and drug development will be greatly enhanced.Learn more